CD4 and type 1 diabetes mellitus: The results of this study demonstrate, for the first time, that ATRi prevents T1D in the adoptive transfer mouse model by inducing DNA damage in actively proliferating diabetogenic CD4+ T cells, resulting in cell death within this population.